🇺🇸 FDA
Patent

US 11583530

Compounds for the prevention and treatment of medical disorders and uses thereof

granted A61KA61K31/519A61K45/06

Quick answer

US patent 11583530 (Compounds for the prevention and treatment of medical disorders and uses thereof) held by Galectin Sciences, LLC expires Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Galectin Sciences, LLC
Grant date
Tue Feb 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61K, A61K31/519, A61K45/06, A61P, A61P1/16